ChemicalBook > CAS DataBase List > Binodenoson

Binodenoson

Product Name
Binodenoson
CAS No.
144348-08-3
Chemical Name
Binodenoson
Synonyms
SHA 211;SHA 174;MRE 0470;WRC 0470;Binodisine;BINODENOSON;Binodenoson/MRE-0470;2-(cyclohexylmethylidenehydrazino)adenos;2-(cyclohexylmethylidenehydrazino)adenosine;2-[(cyclohexylmethylene)hydrazino]-Adenosine
CBNumber
CB81343021
Molecular Formula
C17H25N7O4
Formula Weight
391.42
MOL File
144348-08-3.mol
More
Less

Binodenoson Property

Melting point:
154-157°
Boiling point:
765.6±70.0 °C(Predicted)
Density 
1.76
storage temp. 
Store at -20°C
solubility 
DMSO : 125 mg/mL (319.35 mM; Need ultrasonic)
pka
6.92±0.70(Predicted)
form 
Solid
color 
White to off-white
InChIKey
XJFMHMFFBSOEPR-XNIJJKJLSA-N
SMILES
OC[C@H]1O[C@@H](N2C3C(=C(N=C(NN=CC4CCCCC4)N=3)N)N=C2)[C@H](O)[C@@H]1O
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Binodenoson Chemical Properties,Usage,Production

Description

Binodenoson, 2-[(cyclohexylmethylene)hydrazino] adenosine (MRE0470), is being developed as a short-acting coronary vasodilator, administered intravenously, as an adjunct to radiotracers in myocardial stress imaging techniques to detect the presence and severity of CAD in patients unable to exercise. The compound is a highly selective agonist at the adenosine A2A receptor and also has a weaker affinity for adenosine A1-, A2B-, and A3-receptor subtypes than adenosine[1].

Uses

2-(cyclohexylmethylidenehydrazino)adenosine is used in the diagnosis of coronary heart disease (adenosine A2A agonist).

Pharmacokinetics

The mean values for the apparent elimination half-life of binodenoson ranged from 7.4 minutes (at 1 g/kg) to 14.9 minutes (6 g/kg), with a slight tendency toward higher values with increasing doses. However, because the plasma concentrations for the lowest dose level (0.4 g/kg) were only marginally higher than the assay's lower limit of quantitation, the plasma concentrations could be determined for a longer period of time at the higher dose levels. On average (harmonic mean), the terminal half-life of binodenoson across all doses was 10±4 minutes[1].

in vitro

Binodenoson (MRE-0470) (30-300 nM) decreases oxidative activity of tumor necrosis factor-α–primed FMLP-stimulated polymorphonuclear leukocytes in human whole blood and acts synergistically with Rolipram.

in vivo

Binodenoson (infused 0-0.9 μg/kg/h; adult Wistar rat; rat bacterial meningitis model), with or without rolipram (0-0.01 μg/kg/h), inhibits pleocytosis and reduces the lipopolysaccharide-induced increase in blood-brain barrier permeability (BBBP), indicative of decreased neutrophil-induced damage.

References

[1] Richard J. Barrett PhD . “Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers.” Journal of Nuclear Cardiology 12 2 (2005): Pages 166-171.

Binodenoson Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Binodenoson Suppliers

T&W GROUP
Tel
021-61551611 13296011611
Fax
+86 21-50676805
Email
contact@trustwe.com
Country
China
ProdList
9895
Advantage
58
Zhengzhou Granlen Sciences, ltd.
Tel
0371-85513397 +86-18610099868;
Email
info@granlen.com
Country
China
ProdList
1842
Advantage
58
NewCan Biotech Limited
Tel
+86-0571-86912261 +8613735419629
Email
sales@newcanbio.com
Country
China
ProdList
9981
Advantage
58
CONIER CHEM AND PHARMA LIMITED
Tel
+8618523575427
Email
sales@conier.com
Country
China
ProdList
49374
Advantage
58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tel
+86-021-61551413 +8618813727289
Email
contact@trustwe.com
Country
China
ProdList
5738
Advantage
58
Wuhan Topule
Tel
+86-02787215551 +86-19945035818
Fax
027-87215551
Email
2936752263@qq.com
Country
China
ProdList
7977
Advantage
58
Wuhan Augda Biotechnology Co., Ltd
Tel
15071299552
Fax
QQ:262933239
Email
262933239@qq.com
Country
China
ProdList
6887
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24644
Advantage
58
Xianning Shen Lan Biomedical Research and Development Co., Ltd.
Tel
18171815831
Email
1341138380@qq.com
Country
China
ProdList
3401
Advantage
58
Suzhou Meishi Biotechnology Co., Ltd.
Tel
1173954148q
Email
meishipharma@126.com
Country
China
ProdList
20033
Advantage
58
Panaishen (Henan) Pharmaceutical Science and Technology Co. , Ltd.
Tel
0371-65325800 13700860222
Email
haifeng.zhang@pannacean.com
Country
China
ProdList
637
Advantage
58
Nantong QuanYi Biotechnology Co., Ltd
Tel
0513-66337626 18051384581
Email
sales@chemhifuture.com
Country
China
ProdList
4988
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11974
Advantage
58
Shanghai Jiahua Herong Biotechnology Co., Ltd
Tel
13296077563 13296077563
Email
hr@bettersyn.com
Country
China
ProdList
9932
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-85560043 15850508050
Fax
025-85563444
Email
cindy.huang@synzest.com
Country
China
ProdList
12005
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525
Email
209533805@qq.com
Country
China
ProdList
9765
Advantage
58
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD
Tel
0371-55159968 18137130222
Email
haifeng.zhang@pannacean.com
Country
China
ProdList
645
Advantage
58
Wuhan Fortuna Chemical Co.,Ltd
Tel
+8618007136271
Email
hk@fortunachem.com
Country
China
ProdList
5998
Advantage
58
Shenzhen Nexconn Pharmatechs Ltd
Tel
+86-755-89396905 +86-15013857715
Email
admin@nexconn.com
Country
China
ProdList
10311
Advantage
58

144348-08-3, Binodenoson Related Search:


  • 2-(cyclohexylmethylidenehydrazino)adenosine
  • (2R,3R,4R,5R)-2-[6-amino-2-((2E)-2-(cyclohexylmethylidene)hydrazinyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
  • BINODENOSON
  • WRC 0470
  • 2-[2-(Cyclohexylmethylene)hydrazinyl]adenosine
  • MRE 0470
  • SHA 174
  • SHA 211
  • Binodisine
  • Adenosine, 2-[2-(cyclohexylmethylene)hydrazinyl]-
  • 2-(Cyclo hexyl methylidene hydrazino) adenosine, Binodenoson
  • 2-(Cyclhexyl methylidene hydrazino) adenosine
  • 2-(cyclohexylmethylidenehydrazino)adenos
  • MRE 0470,imaging,P1 receptor,stress,oxidative,WRC0470,neutrophil,inhibit,radiotracers,Binodenoson,Adenosine Receptor,Inhibitor,WRC-0470,MRE0470,myocardial
  • Binodenoson/MRE-0470
  • 2-[(cyclohexylmethylene)hydrazino]-Adenosine
  • 144348-08-3